De Lau WB - Search Results

1

Absence of preferential homologous H/L chain association in hybrid hybridomas.

De Lau WB, Heije K, Neefjes JJ, Oosterwegel M, Rozemuller E, Bast BJ. De Lau WB, et al. J Immunol. 1991 Feb 1;146(3):906-14. J Immunol. 1991. PMID: 1899099

2

Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.

De Lau WB, Boom SE, Heije K, Griffioen AW, Braakman E, Bolhuis RL, Tax WJ, Clevers H, Bast BJ. De Lau WB, et al. J Immunol. 1992 Sep 15;149(6):1840-6. J Immunol. 1992. PMID: 1387662

3

Production of hybrid hybridomas based on HAT(s)-neomycin(r) double mutants.

De Lau WB, Van Loon AE, Heije K, Valerio D, Bast BJ. De Lau WB, et al. J Immunol Methods. 1989 Feb 8;117(1):1-8. doi: 10.1016/0022-1759(89)90111-7. J Immunol Methods. 1989. PMID: 2913154

4

Enrichment and selection of hybrid hybridomas by Percoll density gradient centrifugation and fluorescent-activated cell sorting.

Koolwijk P, Rozemuller E, Stad RK, De Lau WB, Bast BJ. Koolwijk P, et al. Among authors: de lau wb. Hybridoma. 1988 Apr;7(2):217-25. doi: 10.1089/hyb.1988.7.217. Hybridoma. 1988. PMID: 3372003

5

HB4 antibody recognizes a carbohydrate structure on lymphocyte surface proteins related to HB6, CDw75, and CD76 antigens.

De Lau WB, Kuipers J, Voshol H, Clevers H, Bast BJ. De Lau WB, et al. J Immunol. 1993 Jun 1;150(11):4911-9. J Immunol. 1993. PMID: 8496593

6

Killing of autologous B-lineage malignancy using CD3 x CD19 bispecific monoclonal antibody in end stage leukemia and lymphoma.

Haagen IA, Geerars AJ, de Lau WB, Clark MR, van de Griend RJ, Bast BJ, de Gast BC. Haagen IA, et al. Among authors: de lau wb. Blood. 1994 Jul 15;84(2):556-63. Blood. 1994. PMID: 7517719 Free article.

7

Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3 x CD19 bispecific antibody to proliferate and become cytotoxic.

Haagen IA, de Lau WB, Bast BJ, Geerars AJ, Clark MR, de Gast BC. Haagen IA, et al. Among authors: de lau wb. Cancer Immunol Immunother. 1994 Dec;39(6):391-6. doi: 10.1007/BF01534426. Cancer Immunol Immunother. 1994. PMID: 7528094 Free PMC article.

8

The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2.

Haagen IA, Geerars AJ, de Lau WB, Bast BJ, de Gast BC. Haagen IA, et al. Among authors: de lau wb. Blood. 1995 Jun 1;85(11):3208-12. Blood. 1995. PMID: 7538821 Free article.

9

Putative myeloma precursor cells expressing 2,6 sialic acid-modified antigens actually belong to the erythroid lineage.

de Lau WB, Kuipers J, Peters PJ, Lokhorst HM, Clevers H, Bast BJ. de Lau WB, et al. Leuk Res. 1998 Feb;22(2):163-73. doi: 10.1016/s0145-2126(97)00154-9. Leuk Res. 1998. PMID: 9593473

10

Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains.

Haagen IA, Geerars AJ, Bast EJ, de Gast GC, van de Winkel JG, de Lau WB. Haagen IA, et al. Among authors: de lau wb. Ther Immunol. 1994 Oct;1(5):279-87. Ther Immunol. 1994. PMID: 7584502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters